ArticleJournal of health economics and outcomes research2025

Costs of First-Line Treatment With FOLFIRINOX, Modified FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma.

Syvart Dennen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.